It has been definitely established that Type I antipneumococcus sera is an effective bactericidal agent when administered intravenously to human beings in adequate dosage. In addition there is considerable accumulated evidence to suggest the value of such sera in non-bacteremic cases of Type I pneumococcus lobar pneumonia treated early in the disease. Despite these facts, Type I antiserum has not become a widely used therapeutic agent in the hands of the general practitioner. Besides the expense incident to the use of large quantities of serum, is the fact that in general practice the physician hesitates to administer any medication intravenously, usually reserving such treatment for hospitalized cases, on account of the perhaps unwarranted fear of reactions from serum sensitivity or from such remote accident as thrombosis or embolism. It was therefore thought expedient to determine whether adequate doses of various preparations of Type I antipneumococcus serum administered by the intramuscular route were as efficient in their bactericidal and therapeutic effects as similar doses given intravenously.
In this connection it is worthy to note that the intravenous route of serum administration seemed to have been established by the work of Neufeld and Handel 1 as the only satisfactory means of introducing this therapeutic agent. Apart from the work of Cecil and Baldwin 2 with subcutaneous injection of Huntoon's antibody there does not seem to have been any attempt made to determine by actual com-parison, the superiority of this less convenient route of therapy either on experimental animals or human beings suffering from the disease. This communication proposes to submit evidence based on a comparison of the intramuscular and intravenous routes of treatment of an experimental pneumococcus infection in the rabbit.
Methods
An attempt was made to produce as nearly as possible a constant "standard" infection in the rabbit by the intradermal injection of a standard dose of 18 hour Type I pneumococcus broth culture after the method of Goodner? This acute infection which Goodner names "dermal pneumonia" and believes to resemble in many respects the picture of pneumococcus pneumonia in human beings, was then treated by the administration of equal quantities of different serum preparations given by the intravenous and intramuscular routes respectively, at different times after infection with culture.
In each individual experiment the size of dose and the time of treatment were fixed, the only variable being the route of administration. Moreover, a number of experiments were performed in which the size of the dose and the time of treatment were varied. It was felt that an analysis based on such a method of collecting data would tend to properly allocate the chance probability of biological variation of the experimental animal, a probability that might be iargely operative in producing favorable or unfavorable results if only single experiments, even with large groups of animals, were performed.
Technique
In each experiment 0.1 cc. of a 1 : 100 dilution of an 18 hour blood broth culture of Type I pneumococcus was injected intradermally to one side of the ventral midline of each rabbit weighing from 1800 to 2200 gm. At a given period after infection, the animals were divided into two equal batches and treated with a certain dose of serum by the intravenous and intramuscular routes, the former receiving the dose in the marginal ear vein, the latter deep in the leg muscles immediately adjacent to the gluteal region. A control untreated animal was always included in each experiment to establish the untreated course of the disease for the rabbit. In each experiment a batch of white mice weighing from 18 to 22 gin., were injected intraperitoneaUy with suitable dilutions of the culture, on which blood plates were poured and the number of organisms estimated, so as to establish the full virulence of the culture for mice, as well as to permit of comparison of one set of experiments with another in respect to variations as to virulence and total bacterial content of the infecting culture.
In order to compare the bactericidal effects of the serum by the different routes, blood cultures were taken from the marginal veins just prior to administration of serum and at varying intervals thereafter. It was thus possible to study in each animal the initial height of the bacteremia, the height following treatment, and in many cases in which cultures were taken at frequent intervals after treatment, the rate of sterilization of blood by the different routes of treatment.
As a rule, either seven or eleven rabbits were used in an individual experiment, one being a control untreated animal, the remaining animals being divided into two equal groups and treated by the intravenous and intramuscular routes respectively.
The results of these experiments will be reported according to: (a) the time that elapsed between infection and administration of serum and (b) the size of the therapeutic dose at that given time interval.
Before analyzing the results of the various experiments, only animals that had survived the intradermal injection for a 10 day period, after injection, were included as survivals. This time interval places a rigid control on our figures, as in tests of a similar nature in which highly susceptible animals are infected with virulent cultures of the pneumococcus, e.g. the mouse protection test, the time of expiration of the test has been arbitrarily fixed at a much shorter time interval (the mouse protection test covers a period of 5 days).
Similarly in order to exclude, as much as possible, animals dying from causes other than pneumococcus infection, only those dying within 10 days and showing on autopsy, pneumococci in either culture of the heart's blood or the local lesion or of the brain, were included in the analysis of the results, those dying with negative cultures being discarded entirely from the series.
The present analysis is then based on a study of 181 rabbits treated at different times with different doses of various serum preparations by the intravenous and intramuscular routes.
Animals Treated at 24 Hour Interval
In this group several dose levels were investigated, the dose ranging from 400 units* to 2500 units. In those experiments in which the smaller doses (e,g. 400 units and 800 units) were used, the death rate following treatment was high, irrespective of the route of administration or the nature of the therapeutic agent.
For example, in the 400 unit group, a serum prepared by the use of pneumococcus exudate as antigen ~ (Foundation Preparation 15), was compared with one prepared by the standard method of immunization with formalinized pneumococcus vaccine (Standard Preparation 14) (Table I) .
From Table I it is evident that the doses used were subeffective, there being a relatively low survival rate for each preparation. In the case of those animals receiving 800 units (Table II) , it is seen that the survival rate rises for both the "exudate" and the "vaccine" sera, the percentage of survivals still suggesting a subeffective zone of therapy, however. It is of interest to note that the survival rate of the animals receiving Felton's antibody intravenously was higher than either of the unrefined sera administered by the same Curphey, T. J., and Baruch, H. B., Proc. Soc. Exp. Biol. and Med., 1929, 26, 687, 688. route, whereas the survival rate on the intramuscular dosage of this preparation, was definitely lower than that of the exudate antiserum (Preparation 15) but higher again than that of the vaccine antiserum (Preparation 14). Whether this can be interpreted as evidence in favor of the greater therapeutic effect of exudate antisera administered intramuscularly is open to question, as the number of animals in this group is obviously too small to warrant any such conclusion being drawn.
With the use of larger doses of serum, e.g. 2500 units, it is seen from Table III that such a dose lies in the effective zone of therapy, the intravenous administration of both preparations causing relatively high survival rates. On the other hand the animals obtaining treat- ment by the intramuscular route on the standard serum showed a lower survival rate than did those on the exudate antiserum, a fact which also appeared evident at both the previous dose levels of 800 and 400 units respectively. Moreover, from a comparison of Tables  I to III , it is seen that in the case of the standard unrefined antiserum, there appears to be a proportionate relationship between the increase in the survival rates by either route of treatment and the number of units of serum administered. In the case of this preparation, the number of animals surviving after the intramuscular dosage is from one-half to one-third less than those receiving serum intravenously. On the other hand, there is a much wider disparity evident when the results of the intramuscular dosage of the exudate antiserum are considered, for while the survivals on the intravenous dosage with this preparation are in proportion to the increase in the unit size of the dose, the survivals on the intramuscular dosage at the 400 and 800 unit levels are actually greater in both instances than those in the intravenous group, a fact in distinct contrast to the observations on the standard sera. One might easily infer from this that the therapeutic effects of the exudate antisera when administered intramuscularly, bear little proportional relationship to the number of antibacterial units administered.
A further inference that is perhaps not unwarranted on the face of the collected data would be that the intramuscular route of dosage represents the more favorable method of injecting exudate antisera.
The Relationship between the Roule of Dosage and the Degree of Bacteremia
It seemed important to know what relationship existed between the route of serum dosage and the extent of bacterial invasion of the blood at the time of administration of the serum. In Tables I to III where an analysis was based on the size of the dose administered, no account was taken of the height of the bacteremic level in the individual animal at the time of treatment. It is obvious that this factor must be considered in order to correctly evaluate the value of intramuscular serum dosage, as in the rabbit there is a very wide variation in the individual response to a standard dose of pneumococci (Type I) injected intradermally in so far as the number of organisms present in the blood at the end of a given period after infection is concerned. That this variation in individual animals to bacterial invasion has its counterpart in human beings, is beyond doubt. In order, then to determine the effect of intramuscular dosage, it appeared necessary to compare the effect of such dosage with the intravenous route in a group of animals having the same relative bacteremic level at the time of treatment. For purposes of comparison, three arbitrary levels were chosen representing for the rabbit, cases of mild, moderately severe and severe blood invasion. The results of several experiments were studied collectively, at two fixed dose levels, i.e. 800 units and 2500 units, the animals being divided into the three bacteremic groups (Tables IV and V) .
Unfortunately, with such a division, the number of animals falling in each bacteremic group is small, and while this considerably vitiates any comparison, nevertheless, the results obtained show a definite relationship between the outcome of the infection and the height of the bacteremia, being more dependent on the latter than on the route of dosage. This is especially true in the case of Felton's antibody at the lower dose level (800 units). The apparent irregularities seen at the higher dose level (2500 units) in which, in the case of Preparation 14, there is actually a higher survival rate on intramuscular dosage at the moderate bacteremic level than at the mild bacteremic level, might be taken as due partly to the small number of animals falling in each group and party to the adequacy of the larger dose in dealing with the higher bacteremic levels. However, the figures do show that the survival rate in the animals treated intramuscularly is as great as in those treated by the intravenous route with Preparation 15, 2500 units at the mild bacteremic level and 800 units at the moderate bacteremic level. In order to compare the efficacy of intramuscular dosage with that of intravenous dosage, an analysis was made of 83 rabbits that had had blood cultures taken at the time of treatment, the animals being divided into groups on the basis of blood stream invasion into those with mild, moderate and severe bacteremias, irrespective of the amount of serum administered, the comparison being dependent on route of dosage and height of bacterial invasion at the time of treatment. Table VI shows the results of such a comparison. Thus in the animals with mild blood invasion, the survival rates for Preparation 15 and Felton's antibody show that intramuscular dosage in the case of the former is as efficient and in the case of the latter nearly as efficient as intravenous dosage. In the group with moderate blood invasion the Felton's antibody given intramuscularly is as efficient as the intravenous dose, while Preparation 15 on the other hand, is Slightly less efficient when given intramuscularly. The figures in the B. BARUCH The above analysis is based purely on the height of bacteremic level at time of treatment, irrespective of size of dose of serum used in treatment. group with severe blood stream invasion show that little can be expected by intramuscular administration. They also show, however, a low survival rate on intravenous administration, and this, despite the fact that many animals in this group were treated with large doses of serum. This would seem to agree with the clinical experience in the case of overwhelming bacteremias complicating the local lesion, where, irrespective of the total amount of serum given intravenously, the therapeutic result is uniformly poor.
Animals Treated at 6 Hour Interval
While most of the experiments were performed at the longer time interval, data were collected on 57 rabbits treated with different doses of serum between 6 to 8 hours after the standard intradermal infection. Table VII shows the comparison between intravenous and intramuscular dosage with a subeffecfive dose (200 units) of Preparation 15. The ineffectiveness of such a dose administered intramuscularly is striking. This is undoubtedly due to the diminished concentration of bactericidal antibody in the blood, the result of slower absorption by the intramuscular route. That the effect is not entirely dependent on the rate of absorption, however, will be shown later in the case of effective doses of serum.
If a larger unit dosage (400 units) in the subeffective zone of therapy be used, it is seen from Table VIII that the survival rate following intramuscular dosage rises. Similarly if the survival rate of this group is considered regardless of the preparation used, but wholly on a comparison of the route of therapy, it is seen that the survival rate on the intramuscular dosage of all four preparations is somewhat greater (60 per cent) than that of the same preparations on the intravenous dosage (48 per cent). There thus appears to be sufficient evidence in favor of the therapeutic value of pneumococcus antisera given by the intramuscular route.
The Bactericidal Effect of Intramuscular Doses of Serum
An attempt was made to compare the sterilizing effect of similar doses of the same antiserum given by the intravenous and the intra- fig. 1 ) shows that the sterilizing effect at the end of a given time after serum administration by the intramuscular route is as great as that seen during the same time by the intravenous route. This result was noted constantly in a number of experiments, the only exception being in cases with very severe bacteremias where the reduction in the number of organisms following intramuscular dosage was not always as great as that following intravenous dosage.
DISCUSSION
Certain definite facts appear evident from an analysis of the foregoing data. Thus it seems that while the extent of survival of animals receiving different preparations of antipneumococcus sera by the two routes, the intramuscular and intravenous, varies according to the preparation, the size of the injected dose and the initial height of the bacteremia at the time of serum administration, nevertheless it appears that these factors are independent of the route of administration, for when animals grouped under these different heads, e.g. size of dose, time of treatment, etc., are considered collectively according to the route of dosage only, the total survival rate by the intramuscular route is found to be, with the exudate antiserum, nearly as high and at times even higher than the survival rate by the intravenous route of treatment, while with the standard vaccine antiserum the intramuscular route appears to be less satisfactory.
Furthermore, on considering the sterilizing effect of intramuscular doses of serum in individual rabbits, it is seen that despite the indirect route, the bacteremic level falls as rapidly in the few cases tested as by the intravenous route, except in cases where there is very severe bacteremia.
The practical application of this experimental evidence is obvious. If the same thing is true for the human case of lobar pneumonia with bacteremia as is true for dermal pneumonia in rabbits it would then appear unnecessary to continue the present method of intravenous therapy, except in the severe cases of bacteremia, the intramuscular route being likely to be nearly as effective, besides having the additional advantages of convenience and being less liable to untoward results. If this is found to be true in human beings, and evidence at present being accumulated points Strongly to that possibility, then the use of intramuscular therapy in pneumonia should make the serum treatment of the disease more popular in the hands of the general practitioner than it has been in the past. CONCLUSIONS 1. Intramuscular dosage of antipneumococcus sera in a standard dermal pneumococcic infection in rabbits is as effective as intravenous dosage provided the degree of blood stream invasion be not unusually high.
2. The immediate bactericidal effect of doses of serum given intramuscularly is equal to that of the same doses given intravenously in the cases of mild and moderately severe bacteremias.
3. The intramuscular method of serum administration in human beings with lobar pneumonia deserves a carefully controlled clinical trial.
